Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 2:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2521–2544 of 6,936 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control, small Clear all

Conditions: Lower Limb Amputation Above Knee (Injury), Congenital Amputation of Lower Limb, Lower Limb Amputation Knee
Interventions: Kenevo or C-Leg 4, Non microprocessor controlled knee (NMPK); Device
Lead sponsor: Otto Bock Healthcare Products GmbH; Industry
Eligibility: 65 Years and older
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 90
States / cities: Dothan, Alabama • Gilbert, Arizona • Phoenix, Arizona + 85 more

Conditions: Reading Learning Disability, Math Learning Disability
Interventions: Reading Intervention, Math Intervention, Coordinated Intervention; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 6 Years to 8 Years
Enrollment: 385 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Pain, Acute, Patient Satisfaction
Interventions: Lidocaine 2% Injectable Solution, Buzzy; Drug · Device
Lead sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.; Other
Eligibility: 18 Years to 99 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Brighton, Massachusetts

Conditions: Overweight or Obesity
Interventions: JITAI Combined with psychological intervention, Active Control; Behavioral
Lead sponsor: ORI Community and Evaluation Services; Other
Eligibility: 18 Years to 75 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Springfield, Oregon

Conditions: Anxiety, Well-Being, Satisfaction
Interventions: Spiritual Care Assessment and Intervention (SCAI) Framework, ICU Guide; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: San Francisco, California • Winston-Salem, North Carolina

Conditions: Small Cell Lung Cancer
Interventions: Tiragolumab, Atezolizumab, Carboplatin, Etoposide, Placebo; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 490 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 18
States / cities: Lone Tree, Colorado • Washington D.C., District of Columbia • Fort Myers, Florida + 15 more

Conditions: Labor Pain, Obstetric Pain
Interventions: CADD-Solis pump (Smiths Medical); Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc, SCLC,Extensive Stage, Lung Cancer, Lung Cancer Metastatic, Lung Cancer Stage IV
Interventions: BL-M14D1 and Atezolizumab, Carboplatin+ Etoposide + Atezolizumab followed by Atezolizumab and Lurbinectedin; Drug
Lead sponsor: SystImmune Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 7
States / cities: Springdale, Arkansas • Glendale, California • Long Beach, California + 4 more

Conditions: Music Exposure
Interventions: Music in Sport Based Youth Development, No Music Exposure; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 10 Years to 12 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Rheumatoid Arthritis (RA)
Interventions: Non-invasive ultrasound stimulation of the spleen - Treatment Setting 1, Non-invasive ultrasound stimulation of the spleen - Treatment Setting 2, Sham ultrasound stimulation (control), Conventional Synthetic DMARD; Device · Drug
Lead sponsor: SecondWave Systems Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 5
States / cities: Glendale, Arizona • Covina, California • Temecula, California + 2 more

Conditions: Sleep, Fatigue
Interventions: Sleep Environment Intervention, Normal Hospital Environment; Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 4 Years to 21 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Interventions: Sham Intervention, Survey Administration, Transcranial Direct Current Stimulation; Procedure · Other · Device
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Coronavirus Infections, Pneumonia, Viral, Acute Respiratory Distress Syndrome
Interventions: Nitric Oxide; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Shreveport, Louisiana • Boston, Massachusetts

Conditions: Mild Traumatic Brain Injury
Interventions: Passive neurosensory reintegration training (PNRT); Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Clostridium Difficile
Interventions: Bezlotoxumab; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 60 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Momelotinib, Placebo to match momelotinib, Nab-paclitaxel, Gemcitabine; Drug
Lead sponsor: Sierra Oncology LLC - a GSK company; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 4
States / cities: Los Angeles, California • Goshen, Indiana • Boston, Massachusetts + 1 more

Conditions: Aging
Interventions: Motor Practice of a Standing Serial Reaction Time Task; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 95 Years
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Atrial Fibrillation
Interventions: Ondansetron 8mg, Placebo; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 3
States / cities: Indianapolis, Indiana

Conditions: Peripheral Artery Disease (PAD), Ischemia, Intermittent Claudication
Interventions: Chocolate Touch, Lutonix Drug Coated Balloon; Device
Lead sponsor: TriReme Medical, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 333 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 15
States / cities: Gainesville, Florida • Miami Beach, Florida • Atlanta, Georgia + 11 more

Conditions: Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis
Interventions: Magnetic Resonance Elastography (MRE), Liver biopsy; Other · Diagnostic Test
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 152 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 2
States / cities: La Jolla, California • Madison, Wisconsin

Conditions: Stroke, Hemiparesis
Interventions: Action Observation + Repetitive Task Practice, Placebo Video + Repetitive Task Practice; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Disordered Eating Behaviors
Interventions: Prevention Course Group; Behavioral
Lead sponsor: University at Buffalo; Other
Eligibility: 18 Years to 24 Years · Female only
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Reward Value Level
Interventions: Socially Evaluated Cold Pressor Task (SECPT), Non-Stressful Control Task; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Sleep, Wearable Technology, Cortisol, Healthy Participants, Cognitive Abilities
Interventions: PeptiSleep, Micro-crystalline cellulose; Dietary Supplement
Lead sponsor: Nuritas Ltd; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Wilmington, Delaware

Search by objective public record fields.

Assessing Outcomes With Microprocessor Knee Utilization in a K2 Population

Improving the Academic Performance of First-Grade Students With Reading and Math Difficulty

Pilot Trial: Comparing Buzzy to Intradermal Lidocaine for Peripheral IV Cannulation in Adults

Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight Regain

Supporting Families in the ICU

A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

Association Between Bolus Rate and the Adequacy of Labor Analgesia Using Timed-intermittent Boluses

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

Testing the Effects of Music on Short and Long Term Psychological Outcomes and Step Counts in Children

At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]

A Pilot Study to Examine Sleep and Fatigue in Pediatric Brain Tumor Patients Hospitalized for High Dose Chemotherapy

Transcranial Direct Current Stimulation for the Treatment of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19

Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury

Bezlotoxumab as Secondary Prophylaxis for C. Difficile in High-risk Hospitalized Patients Exposed to Antibiotics.

Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Does Overpractice Improve Motor Learning?

Ondansetron for the Management of Atrial Fibrillation

The Chocolate Touch Study

Technical Validation of MR Biomarkers of Obesity-Associated NAFLD

Feasibility of Action Observation and Repetitive Task Practice on Upper Extremity Outcomes in Chronic Stroke Survivors

Effects of a Yoga-Based Course in Preventing Disordered Eating in Female Collegiate Athletes

Stress and Anxiety Effects on Valuation

Effects of PeptiSleep on Sleep Quality in Healthy Adults